Caspase-3 and Survivin Expression in Primary Atypical and Malignant Meningiomas
ISRN Neuroscience · 2013
DOI: 10.1155/2013/626290 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Neuroscience, 2013. Verfasst von Andrej Vranic. Beteiligte Einrichtung: Department of Neurosurgery, University Medical Center Ljubljana, Zaloska 7, 1525 Ljubljana, Slovenia ; Génomique Fonctionnelle des Tumeurs Solides, U…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Objective
Information about possible prognostic factors of the survival of patients with atypical and malignant meningiomas (AMM) is sparse. The aim of our study was to evaluate prognostic significance of apoptotic marker caspase-3 and apoptotic inhibitor survivin in a series of primary AMM.
Methods
86 AMM (76 atypical and 10 malignant) were analyzed. Caspase-3 and survivin expression was evaluated immunohistochemically. The correlation between caspase-3, survivin, and other possible factors of meningioma recurrence was evaluated. Uni- and multivariate recurrence-free survival (RFS) and overall survival (OS) analyses were performed.
Results
The intensity of caspase-3 expression correlated with the tumor grade ( P = 0.004 ), the proliferation index ( P = 0.019 ), and the mitotic count ( P = 0.013 ). Survivin tended to be more expressed in female patients ( P = 0.072 ). Survivin expression was stronger in malignant compared to atypical meningiomas, however, the difference was not statistically important ( P = 0.491 ). Neither survivin nor caspase-3 expression significantly predicted OS or RFS in patients with AMM.
Conclusions
Strong caspase-3 expression on AMM cells could reflect a cellular attempt at the homeostatic autoregulation of the tumor size. Survivin expression on AMM cells is similar to the survivin expression reported on benign meningiomas. Caspase-3 and survivin expression has no prognostic significance on the survival of patients with AMM.
Autor:innen und Institutionen
- Department of Neurosurgery, University Medical Center Ljubljana, Zaloska 7, 1525 Ljubljana, Slovenia ; Génomique Fonctionnelle des Tumeurs Solides, Unité INSERM U674, 75010 Paris, France.
Zitieren
APA
Vranic, A. (2013). Caspase-3 and Survivin Expression in Primary Atypical and Malignant Meningiomas. ISRN Neuroscience. https://doi.org/10.1155/2013/626290
Vancouver
Vranic A. Caspase-3 and Survivin Expression in Primary Atypical and Malignant Meningiomas. ISRN Neuroscience. 2013. doi:10.1155/2013/626290
BibTeX
@article{Vranic2013,
author = {Vranic, Andrej},
title = {Caspase-3 and Survivin Expression in Primary Atypical and Malignant Meningiomas},
journal = {ISRN Neuroscience},
year = {2013},
doi = {10.1155/2013/626290}
}
EUVIMED